Bortezomib in the Treatment of Multiple Myeloma

Bortezomib in the Treatment of Multiple Myeloma

Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Ghobrial, Irene M. (Editor), Richardson, Paul G. (Editor), Anderson, Kenneth C. (Editor)
Format: Electronic eBook
Language:English
Published: Basel : Springer Basel : Imprint: Springer, 2011.
Series:Milestones in Drug Therapy
Subjects:
Medicine.
Cancer research.
Pharmacology.
Oncology.
Apoptosis.
Medicine & Public Health.
Cancer Research.
Pharmacology/Toxicology.
Online Access:Full Text via HEAL-Link

Internet

Full Text via HEAL-Link

ΒΚΠ - Πατρα: ALFd

Holdings details from ΒΚΠ - Πατρα: ALFd
Call Number: 330.01 BAU
Copy 1 Available

ΒΚΠ - Πατρα: BSC

Holdings details from ΒΚΠ - Πατρα: BSC
Call Number: 330.01 BAU
Copy 2 Available
Copy 3 Available

Similar Items